Breathe Well Live Well
Condition: Asthma
Interventions: Drug: Treatment A: Fp MDPI; Drug: Treatment B: FS MDPI; Drug: Treatment C Flovent; Drug: Treatment D: Advair
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Research and Markets: GSK's Flovent (Asthma) – Forecast and Market Analysis …
Business Wire (press release) Originally approved by the Food and Drug Administration (FDA) in 1996, GSK's Flovent (fluticasone propionate) is a synthetic ICS therapy with potent anti-inflammatory activity. It is used for the maintenance treatment of asthma prophylactically in … Research and Markets: GSK's Bosatria (Mepolizumab) Asthma Treatment … |
View full post on asthma – Google News
NerdWallet (blog) |
Saving on Asthma Medications: Albuterol, Advair, Flovent and Singulair
NerdWallet (blog) Saving money on the most commonly sought medications for asthma—albuterol, Advair, Flovent and Singulair—is important, especially for sufferers of a lifelong condition and those with tight budgets. After all, many patients cite cost as a reason for … |
View full post on asthma – Google News